BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17854971)

  • 1. Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity.
    Cairney CJ; Keith WN
    Biochimie; 2008 Jan; 90(1):13-23. PubMed ID: 17854971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
    Atkinson SP; Hoare SF; Glasspool RM; Keith WN
    Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms involved in the regulation of telomerase activity].
    Liu WJ; Ding J
    Sheng Li Ke Xue Jin Zhan; 2001 Jul; 32(3):220-4. PubMed ID: 12545793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of telomerase reverse transcriptase gene in human mammary epithelial cells with limiting telomerase RNA expression levels.
    Cao Y; Huschtscha LI; Nouwens AS; Pickett HA; Neumann AA; Chang AC; Toouli CD; Bryan TM; Reddel RR
    Cancer Res; 2008 May; 68(9):3115-23. PubMed ID: 18451136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts.
    Swiggers SJ; Nibbeling HA; Zeilemaker A; Kuijpers MA; Mattern KA; Zijlmans JM
    Exp Cell Res; 2004 Jul; 297(2):434-43. PubMed ID: 15212946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
    Nowak T; Januszkiewicz D; Zawada M; Pernak M; Lewandowski K; Rembowska J; Nowicka K; Mankowski P; Nowak J
    Oncol Rep; 2006 Aug; 16(2):301-5. PubMed ID: 16820907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress on telomere and telomerase].
    Yang X; Tao M
    Wei Sheng Yan Jiu; 2004 May; 33(3):369-71. PubMed ID: 15211818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
    Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
    Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.
    Weinrich SL; Pruzan R; Ma L; Ouellette M; Tesmer VM; Holt SE; Bodnar AG; Lichtsteiner S; Kim NW; Trager JB; Taylor RD; Carlos R; Andrews WH; Wright WE; Shay JW; Harley CB; Morin GB
    Nat Genet; 1997 Dec; 17(4):498-502. PubMed ID: 9398860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation.
    Marie-Egyptienne DT; Cerone MA; Londoño-Vallejo JA; Autexier C
    Nucleic Acids Res; 2005; 33(17):5446-57. PubMed ID: 16192571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization.
    Soder AI; Going JJ; Kaye SB; Keith WN
    Oncogene; 1998 Feb; 16(8):979-83. PubMed ID: 9519871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-telomeric activities of telomerase.
    Majerská J; Sýkorová E; Fajkus J
    Mol Biosyst; 2011 Apr; 7(4):1013-23. PubMed ID: 21283914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-throughput assay for a human telomerase protein-human telomerase RNA interaction.
    Keppler BR; Jarstfer MB
    Anal Biochem; 2006 Jun; 353(1):75-82. PubMed ID: 16620757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
    de Souza Nascimento P; Alves G; Fiedler W
    Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell redox state and mitochondria at the center of the non-canonical activity of telomerase reverse transcriptase.
    Indran IR; Hande MP; Pervaiz S
    Mol Aspects Med; 2010 Feb; 31(1):21-8. PubMed ID: 19995569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advance of research on telomerase].
    Hiyama K; Ishioka S; Hiyama E; Yamakido M
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1105-10. PubMed ID: 9679570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.
    Bilsland AE; Merron A; Vassaux G; Keith WN
    Cancer Res; 2007 Feb; 67(3):1299-307. PubMed ID: 17283167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells.
    Napier CE; Veas LA; Kan CY; Taylor LM; Yuan J; Wen VW; James A; O'Brien TA; Lock RB; MacKenzie KL
    Biochim Biophys Acta; 2010 Oct; 1803(10):1142-53. PubMed ID: 20619302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of telomerase activity by preventing proper assemblage.
    Keppler BR; Jarstfer MB
    Biochemistry; 2004 Jan; 43(2):334-43. PubMed ID: 14717587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.